INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2014

In patients with type 2 diabetes and lipid abnormalities, green tea extract improved insulin resistance and glucagon-like peptide 1 only within the group.

Ninety-two patients with type 2 diabetes and lipid abnormalities were randomized to take 500 mg green tea extract or cellulose placebo three times daily for 16 weeks; 39 in the intervention arm and 38 controls completed the study. Within-group comparisons showed green tea extract significantly decreased triglycerides and HOMA-IR (from 5.4±3.9 to 3.5±2.0), increased HDL-C, and increased glucagon-like peptide 1. Adiponectin, apolipoprotein A1, and apolipoprotein B100 increased significantly in both arms. However, in between-group comparisons, only a decreasing trend in triglycerides was observed.

Study type
Randomized, double-blind, placebo-controlled trial
Who was studied
92 subjects with type 2 diabetes mellitus and lipid abnormalities (77 completed)
What was measured
Glycemic and lipid profiles, anthropometrics, safety parameters, obesity-related hormone peptides

THE PAPER

Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial.

Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH. PLoS One, 2014.

PubMed 24614112 ↗DOI 10.1371/journal.pone.0091163 ↗

Heart & arteriesDiabetes & blood sugar

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.